马洛拉克的打击:K-Ras-G12D的阿基里斯的脚跟
Christos Adamopoulos1, Kostas A Papavassiliou2, Athanasios G Papavassiliou3
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Trends in pharmacological sciences
|April 23, 2024
概括
研究人员开发了一种新型的共价抑制剂,针对胰腺癌中常见的K-Ras-G12D突变. 这种突破性的化合物在临床前模型中有效降低了瘤生长和瘤信号.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 基尔斯顿大鼠肉瘤病毒瘤基因同类蛋白 (K-Ras) 蛋白在细胞信号传递中起着至关重要的作用.
- 在胰腺癌中经常发现K-Ras的突变,特别是G12D变异,推动瘤生长.
- 向K-Ras突变在癌症治疗中是一个重大挑战.
研究的目的:
- 设计和合成一种针对K-Ras-G12D突变的第一类共价抑制剂.
- 在胰腺癌的临床前模型中评估这种新型抑制剂的疗效.
主要方法:
- 利用基于马洛拉克的电友来利用抑制剂设计的应变释放.
- 开发了一种体抑制剂,专门针对K-Ras-G12D变体.
- 评估该化合物对相关癌症模型中的瘤信号通路和瘤生长的影响.
主要成果:
- 成功设计和合成了一种针对K-Ras-G12D的新型共价抑制剂.
- 该抑制剂显著抑制了瘤原体信号传递.
- 在临床前K-Ras-G12D突变胰腺癌模型中观察到瘤生长的急剧减少.
结论:
- 这项研究为K-Ras-G12D突变胰腺癌提供了一种有前途的第一类共价抑制剂.
- 这些发现扩大了治疗策略,超出了现有的K-Ras-G12C抑制剂.
- 这代表了针对胰腺癌中普遍存在的瘤原因驱动因素的重大进展.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Antihypertensive Drugs: Potassium-Sparing Diuretics
527
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
527
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K


